Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05528380 · ClinicalTrials.gov registry record · NA
Development of a Lifestyle Physical Activity Intervention to Reduce Risk for Perinatal Cannabis Use
A NA study, sponsored by Butler Hospital.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT05528380: Completed NA study, sponsored by Butler Hospital.
NCT05528380 is a NA study that has completed, run by Butler Hospital. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05528380, a NA study, has completed, sponsored by Butler Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This study will recruit 20 women who are high risk for prenatal cannabis use for a 12-week program of using the tracker and receiving a Lifestyle Physical Activity program. The primary outcomes will be self reported percent days of cannabis use and physical activity. Secondary outcomes include self -reported measures of depression and anxiety symptoms, adaptive coping, and self-efficacy for cannabis abstinence.
Primary Outcome
Number of participants using cannabis at week 12, assessed via the Timeline Follow Back
Interventions
- BEHAVIORAL LPA + Fitbit Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2022-01-30 |
| Est. Completion | 2024-10-15 |
| Phase | NA |
What the finished NCT05528380 record still lists
NCT05528380 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which LPA + Fitbit Intervention is the first listed.
NCT05528380 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05528380 about?
NCT05528380 is a clinical study titled "Development of a Lifestyle Physical Activity Intervention to Reduce Risk for Perinatal Cannabis Use". This study will recruit 20 women who are high risk for prenatal cannabis use for a 12-week program of using the tracker and receiving a Lifestyle Physical Activity program. The primary outcomes will be self reported percent days of cannabis use and physical activity. Secondary outcomes include self ...
What is the current status of trial NCT05528380?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2022-01-30. Estimated completion is 2024-10-15.
What interventions are being tested in trial NCT05528380?
The interventions under investigation include: LPA + Fitbit Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05528380?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05528380's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI